An Phase III Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With PsO
Conditions: Plaque Psoriasis Patients Interventions: Drug: 608 Q2W; Drug: 608 Q4W Sponsors: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
A Study of JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
Conditions: Generalized Pustular Psoriasis; Erythrodermic Psoriasis Interventions: Drug: JNJ-77242113 Sponsors: Janssen Pharmaceutical K.K. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
TYK2 Inhibition in Paradoxical Psoriasis
Conditions: Psoriasis Interventions: Drug: Deucravacitinib Sponsors: Prof Curdin Conrad; Centre Hospitalier Universitaire Vaudois Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Effect of Silymarin Against Methotrexate-induced Liver Injury in Rheumatic Diseases
Conditions: Rheumatoid Arthritis; Psoriatic Arthritis; Psoriasis Interventions: Drug: Silymarin; Drug: Placebo Sponsors: Phramongkutklao College of Medicine and Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate-to-Severe Plaque Psoriasis
Conditions: Plaque Psoriasis Interventions: Drug: D-2570; Drug: Placebo Sponsors: InventisBio Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
An Exploratory Study to Evaluate a Digital Intervention to Disrupt Scratching in Atopic Dermatitis and Psoriasis
Conditions: Psoriasis; Atopic Dermatitis Interventions: Device: CT-100-004-A; Device: CT-100-004-B Sponsors: Click Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
Impact of the Mediterranean Diet on Patients With Psoriasis
Conditions: Psoriasis; Psoriasis Vulgaris; Hyperlipidemias; Depression; Anxiety; Metabolic Syndrome; Obesity Interventions: Other: High-intensity Mediterranean diet intervention Sponsors: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in Korea
Conditions: Moderate-to-severe Plaque Psoriasis Interventions: Drug: Deucravacitinib Sponsors: Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
Study to Evaluate the Effectiveness of Risankizumab in Participants With a Recent Diagnosis of Moderate Plaque Psoriasis in a Real-life Setting in Greece
Conditions: Moderate Plaque Psoriasis; Moderate Psoriasis; Psoriasis Sponsors: AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
Investigational Targeted Oral Peptide JNJ-2113 Demonstrated Positive Results in Moderate-to-Severe Plaque Psoriasis in Phase 2b study Published in New England Journal of Medicine
SPRING HOUSE, Penn., Feb. 7, 2024 /PRNewswire/ -- Johnson& Johnson today announced publication in the New England Journal of Medicine (NEJM) of the Phase 2b FRONTIER 1 trial results for JNJ-2113.1 JNJ-2113 is the first and only... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 7, 2024 Category: Pharmaceuticals Source Type: clinical trials
Role of Insulin Action in Psoriasis Pathogenesis
Conditions: Psoriasis; Plaque Psoriasis; Insulin Resistance; PreDiabetes; Overweight and Obesity Interventions: Diagnostic Test: Oral glucose tolerance test (OGTT); Procedure: Skin punch biopsy Sponsors: Columbia University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of HB0034 in Patients With Generalized Pustular Psoriasis (GPP)
Conditions: Generalized Pustular Psoriasis (GPP) Interventions: Drug: HB0034; Other: Placebo Sponsors: Shanghai Huaota Biopharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
A Clinical Trial of TQH3906 Capsules in Healthy Volunteers
Conditions: Psoriasis Interventions: Drug: TQH3906 capsule; Drug: TQH3906 placebo Sponsors: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)
Conditions: Plaque Psoriasis Interventions: Drug: JNJ-77242113; Drug: JNJ-77242113 Matching Placebo; Drug: Deucravacitinib; Drug: Deucravacitinib Matching Placebo Sponsors: Janssen Research& Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials
Smart Phone Delivered Cognitive Behavioral Therapy for Adults With Psoriasis and Co-Morbid Depression Symptoms
Conditions: Psoriasis; Depressive Symptoms Interventions: Other: Coach-guided smartphone delivered CBT program. Sponsors: Brigham and Women ' s Hospital; National Psoriasis Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
